In response to a recent declaration by the World Health Organization (WHO) regarding the global emergency posed by mpox, Congolese authorities have initiated a vaccination campaign aimed at curbing the outbreak. Originating in Congo, the mpox virus has rapidly spread across various African nations and even beyond, leading to widespread concern.
To assist in these efforts, the European Union and the United States have donated 265,000 vaccine doses, which are currently being administered in Goma, located in North Kivu province. This area has seen hospitals overwhelmed by a new strain of the virus, exacerbating an already dire situation. Dr. Jean Bruno Ngenze from the WHO has noted the heightened risk of a significant outbreak in North Kivu, particularly due to crowded conditions in camps for displaced people. The region is currently grappling with one of the largest humanitarian crises in the world, driven by ongoing armed violence.
The gravity of the mpox situation in Congo cannot be understated, with around 30,000 suspected cases reported this year and 859 deaths. This alarming statistic accounts for over 80% of Africa’s total cases and nearly all recorded deaths from the disease. Notably, all 26 provinces in Central Africa have reported cases, highlighting the widespread nature of the outbreak.
While the majority of infections and fatalities are occurring in children under the age of 15, the current vaccination campaign primarily targets adults, particularly at-risk groups and frontline workers. Health Minister Roger Kamba has acknowledged the challenge posed by vaccine shortages across the continent, where only 5.9 million doses have been secured for Africa, expected to arrive between October and December.
The dynamics of mpox transmission have evolved. Previously, the virus was associated primarily with outbreaks in gay and bisexual men. However, it has now begun to spread more widely through sexual transmission and close contact among vulnerable populations, including children and pregnant women. Dr. Dimie Ogoina, a member of the WHO’s mpox emergency committee, has stressed the urgency of addressing these new transmission patterns.
In the face of these challenges, healthcare providers in the region are expressing cautious optimism. Dr. Musole Mulambamunva Robert from Kavumu Hospital has stated that widespread vaccination could be instrumental in halting the spread of mpox, especially in Eastern Congo, which has long been affected by conflict involving over 100 armed groups.
Looking ahead, there is hope on the horizon. Health Minister Kamba has indicated that Japan is expected to supply at least 3 million vaccine doses specifically approved for children in the near future. This is a critical development, given that a substantial number of cases involve children under 15 years of age.
Despite the urgent requests from African governments, the global response to mpox has highlighted disparities in vaccine availability. Wealthy nations have rapidly deployed vaccines, while African countries have received limited supplies, which has hindered the continent’s ability to combat the outbreak effectively.
As of now, over 34,000 suspected mpox cases and 866 deaths have been reported across 16 African countries, marking a 200% increase from the previous year. Access to vaccines remains one of the most significant challenges faced by the continent in its efforts to control the outbreak.
The unfolding situation in Congo underscores the pressing need for sustained international support and cooperation to tackle the mpox outbreak effectively, particularly in vulnerable populations that have borne the brunt of this escalating health crisis.
Read More: Canara Bank Launches online GST Payments through Credit card, Debit Card and UPI